Declines Seen in Medical, Nonmedical Use of Prescription Meds Among Teens
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, July 25, 2024 -- U.S adolescents reported declines in medical use and nonmedical use (NMU) of prescription stimulants, opioids, and benzodiazepines from 2009 to 2022, according to a research letter published online July 24 in the Journal of the American Medical Association.
Sean Esteban McCabe, Ph.D., from the University of Michigan School of Nursing in Ann Arbor, and colleagues examined trends in medical use, NMU, diversion sources, and perceived procurement difficulty of prescription medications for NMU among U.S. adolescents using data from the Monitoring the Future self-administered survey for 2009 to 2022. Data were included for 29,220 adolescents (51.84 percent female).
The researchers found that reported lifetime medical use decreased significantly between 2009 and 2022 (23.66 to 16.00 percent) as did past-year NMU (11.49 to 2.38 percent). Significant declines were seen in trends in two diversion sources from 2009-2010 to 2021-2022: from 57.96 to 26.87 percent for those reporting being given prescription medications from a friend and from 44.35 to 19.42 percent for those reported buying medications from a friend. The most prevalent diversion source in 2021 to 2022 was one's own prescription among adolescents reporting NMU (37.37 percent). There was a decrease in the prevalence of adolescents reporting multiple diversion sources (from 56.27 to 29.33 percent). An increase was seen in the prevalence of adolescents who reported that it would probably be impossible for them to obtain prescription medications for NMU, from 35.56 to 48.96 percent.
"Efforts to further reduce NMU and diversion are needed, particularly given the role of counterfeit pills in the adolescent overdose crisis," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-26 05:15
Read more
- Have an Implanted Defibrillator? Triple-Digit Heatwaves Could Pose Danger
- UCB Receives U.S. FDA Approval for Bimzelx (bimekizumab-bkzx) as the First IL-17A and IL-17F Inhibitor for Adults with Moderate to Severe Hidradenitis Suppurativa
- Bird Flu Infection Confirmed in a Pig for First Time in U.S.
- AHA: Obesity-Linked Ischemic Heart Disease Mortality Increasing in U.S.
- FDA Approves Kebilidi (eladocagene exuparvovec-tneq) Gene Therapy for the Treatment of AADC Deficiency
- UCB Presents Encouraging Data on Bepranemab in Early Alzheimer’s Disease in Phase 2a Study at CTAD 2024
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions